Advanced Medical Isotope Price to Book Ratio 2013-2024 | RDGL
Historical price to book ratio values for Advanced Medical Isotope (RDGL) over the last 10 years. The current price to book ratio for Advanced Medical Isotope as of May 02, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Advanced Medical Isotope Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-01 | 0.14 | 28.55 | |
| 2024-12-31 | 0.11 | $0.00 | 23.45 |
| 2024-09-30 | 0.16 | $0.00 | 56.41 |
| 2024-06-30 | 0.20 | $0.00 | 53.55 |
| 2024-03-31 | 0.07 | $0.00 | 21.26 |
| 2023-12-31 | 0.07 | $0.00 | 20.66 |
| 2023-09-30 | 0.07 | $0.00 | 17.05 |
| 2023-06-30 | 0.05 | $0.00 | 12.18 |
| 2023-03-31 | 0.07 | $0.00 | 17.95 |
| 2022-12-31 | 0.04 | $0.00 | 9.65 |
| 2022-09-30 | 0.05 | $0.01 | 9.81 |
| 2022-06-30 | 0.07 | $0.00 | 27.96 |
| 2022-03-31 | 0.07 | $0.00 | 18.39 |
| 2021-12-31 | 0.08 | $0.00 | 19.72 |
| 2021-09-30 | 0.12 | $0.00 | 29.10 |
| 2021-06-30 | 0.12 | $0.00 | 23.67 |
| 2021-03-31 | 0.10 | $0.01 | 17.86 |
| 2020-12-31 | 0.11 | $0.00 | 1055.00 |
| 2020-09-30 | 0.03 | $0.00 | -7.11 |
| 2020-06-30 | 0.04 | $0.00 | -11.38 |
| 2020-03-31 | 0.03 | $-0.01 | -4.32 |
| 2019-12-31 | 0.04 | $-0.01 | -4.63 |
| 2019-09-30 | 0.04 | $-0.01 | -5.66 |
| 2019-06-30 | 0.03 | $-0.01 | -4.06 |
| 2019-03-31 | 0.02 | $-0.01 | -3.93 |
| 2018-12-31 | 0.06 | $-0.01 | -9.93 |
| 2018-09-30 | 0.14 | $-0.39 | -0.35 |
| 2018-06-30 | 0.02 | $-0.72 | -0.03 |
| 2018-03-31 | 0.24 | $-0.56 | -0.42 |
| 2017-12-31 | 0.40 | $-0.52 | -0.77 |
| 2017-09-30 | 0.57 | $-0.53 | -1.07 |
| 2017-06-30 | 0.66 | $-0.50 | -1.31 |
| 2017-03-31 | 1.21 | $-0.61 | -1.98 |
| 2016-12-31 | 1.40 | $-0.76 | -1.84 |
| 2016-09-30 | 1.68 | $-1.64 | -1.03 |
| 2016-06-30 | 2.96 | $-2.08 | -1.42 |
| 2016-03-31 | 3.76 | $-5.42 | -0.69 |
| 2015-12-31 | 1.84 | $-3.89 | -0.47 |
| 2015-09-30 | 1.12 | $-3.51 | -0.32 |
| 2015-06-30 | 0.72 | $-6.24 | -0.12 |
| 2015-03-31 | 2.80 | $-8.97 | -0.31 |
| 2014-12-31 | 0.72 | $-9.46 | -0.08 |
| 2014-09-30 | 2.88 | 0.00 | |
| 2014-06-30 | 17.52 | $-47.12 | -0.37 |
| 2014-03-31 | 39.84 | $-58.24 | -0.68 |
| 2013-12-31 | 50.40 | $-59.37 | -0.85 |
| 2013-09-30 | 38.40 | $-62.26 | -0.62 |
| 2013-06-30 | 48.00 | $-64.36 | -0.75 |
| 2013-03-31 | 100.80 | $-71.50 | -1.41 |
| 2012-12-31 | 148.00 | $-96.64 | -1.53 |
| 2012-09-30 | 149.60 | 0.00 | |
| 2012-06-30 | 200.00 | 0.00 | |
| 2012-03-31 | 83.20 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | FIN-SBIC&COMMRL | $0.068B | $0.000B |
| Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington. | |||